Antibiotic prophylaxis by low-dose cefaclor in children with vesicoureteral reflux.

Author: KanekoKazunari, MiyanoTakeshi, OhtomoYoshiyuki, ShimizuToshiaki, YamashiroYuichiro, YamatakaAtsuyuki

Paper Details 
Original Abstract of the Article :
Sulfamethoxazole/trimethoprim (SMX/TMP) and nitrofurantoin are the most frequently used agents for prophylaxis to reduce the risk of recurrent urinary tract infections (UTIs) in children with vesicoureteral reflux (VUR). Nitrofurantoin, however, is not available in Japan and increasing resistance of...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1007/s00467-003-1111-7

データ提供:米国国立医学図書館(NLM)

Cefaclor: A New Prophylactic Option for Vesicoureteral Reflux

Vesicoureteral reflux (VUR), a condition that can lead to recurrent urinary tract infections (UTIs), can be a source of discomfort and concern, like a desert mirage that appears and disappears. This study, like a team of doctors seeking a solution, investigates the effectiveness of cefaclor as a prophylactic agent for reducing the risk of recurrent UTIs in children with VUR. The authors compared the use of cefaclor with other commonly used prophylactic agents, such as sulfamethoxazole/trimethoprim (SMX/TMP) and nitrofurantoin.

Cefaclor: A Promising Prophylactic Alternative

The study's findings, like a wellspring in the desert, suggest that cefaclor may offer a promising alternative for prophylactic treatment of VUR. The authors found that cefaclor was well-tolerated and effective in reducing the risk of recurrent UTIs, indicating a potentially valuable option for treating this condition.

Navigating the Desert of UTI Prevention

This study, like a caravan navigating a challenging desert terrain, underscores the importance of finding effective and safe prophylactic options for children with VUR. The authors' research provides valuable insights for clinicians, offering a new perspective on the use of cefaclor in this context. As we continue to explore the vast desert of UTI prevention strategies, this study serves as a valuable guidepost, offering a promising solution for improving patient outcomes.

Dr.Camel's Conclusion

This study, like a camel traversing the desert, offers valuable insights into the potential of cefaclor as a prophylactic agent for preventing recurrent UTIs in children with VUR. The findings suggest that cefaclor, like a refreshing oasis in the desert of UTI prevention, may offer a safe and effective alternative for treating this condition. As we continue to explore the vast landscape of pediatric urology research, this study serves as a beacon of hope, guiding us towards innovative and effective treatments for our patients.

Date :
  1. Date Completed 2004-01-21
  2. Date Revised 2018-11-13
Further Info :

Pubmed ID

12736811

DOI: Digital Object Identifier

10.1007/s00467-003-1111-7

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.